In the days leading up to International Skull Base Surgery Day celebrated on June 4, residents from the Departments of Otolaryngology – Head and Neck Surgery and the Division of Neurosurgery at SIU School of Medicine participated in a highly valuable learning experience—a two-day seminar led by some of the nation’s top skull base surgeons. The seminar blended immersive, skills lab training with in-depth lectures, giving residents a chance to learn directly from internationally recognized leaders from both SIU Medicine and the Cleveland Clinic. This intensive training is part of SIU Medicine’s

In the days leading up to International Skull Base Surgery Day celebrated on June 4, residents from the Departments of Otolaryngology – Head and Neck Surgery and the Division of Neurosurgery at SIU School of Medicine participated in a highly valuable learning experience—a two-day seminar led by some of the nation’s top skull base surgeons. The seminar blended immersive, skills lab training with in-depth lectures, giving residents a chance to learn directly from internationally recognized leaders from both SIU Medicine and the Cleveland Clinic. This intensive training is part of SIU Medicine’s

The Department of Pharmacology at SIU School of Medicine held its 2025 Awards, celebrating the dedication and scientific achievements of its students and researchers. The annual event highlighted their contributions, which are crucial to maintaining SIU's status as an R1 Top-tier Research University . Despite current challenges in the national research landscape, Shelley Tischkau, PhD , chair and professor of pharmacology, reaffirmed SIU’s commitment to rigorous, meaningful science. “Researchers are often expected to work faster, publish more and justify every decision,” she said. “But we

The Department of Pharmacology at SIU School of Medicine held its 2025 Awards, celebrating the dedication and scientific achievements of its students and researchers. The annual event highlighted their contributions, which are crucial to maintaining SIU's status as an R1 Top-tier Research University . Despite current challenges in the national research landscape, Shelley Tischkau, PhD , chair and professor of pharmacology, reaffirmed SIU’s commitment to rigorous, meaningful science. “Researchers are often expected to work faster, publish more and justify every decision,” she said. “But we

The Department of Pharmacology at SIU School of Medicine held its 2025 Awards, celebrating the dedication and scientific achievements of its students and researchers. The annual event highlighted their contributions, which are crucial to maintaining SIU's status as an R1 Top-tier Research University . Despite current challenges in the national research landscape, Shelley Tischkau, PhD , chair and professor of pharmacology, reaffirmed SIU’s commitment to rigorous, meaningful science. “Researchers are often expected to work faster, publish more and justify every decision,” she said. “But we

Mission trip boosts health, builds trust A team of medical providers from Southern Illinois University Center for Family Medicine and Southern Illinois Healthcare (SIH) accompanied SIU School of Medicine resident physicians and students on a mission trip to Costa Rica on March 3-6. The group provided essential medical care to the residents of Isla de Chira, a community of about 3,000. The team raised more than $4,000 to purchase medications and supplies for the trip, allowing them to treat 300+ adults and children during their four-day visit. Isla de Chira residents have limited access to

As a father of six, Donald Torry, PhD, has some experience with pregnancy. Helping women who develop preeclampsia has become his life’s work. Preeclampsia is a pregnancy condition in which high blood pressure and protein in the urine develop after the 20th week (late second or third trimester). Preeclampsia develops in 5-10 percent of pregnancies and, aside from anti-hypertensives to try to control spiraling blood pressure, the only “cure” is delivery.

As a father of six, Donald Torry, PhD, has some experience with pregnancy. Helping women who develop preeclampsia has become his life’s work. Preeclampsia is a pregnancy condition in which high blood pressure and protein in the urine develop after the 20th week (late second or third trimester). Preeclampsia develops in 5-10 percent of pregnancies and, aside from anti-hypertensives to try to control spiraling blood pressure, the only “cure” is delivery.

As a father of six, Donald Torry, PhD, has some experience with pregnancy. Helping women who develop preeclampsia has become his life’s work. Preeclampsia is a pregnancy condition in which high blood pressure and protein in the urine develop after the 20th week (late second or third trimester). Preeclampsia develops in 5-10 percent of pregnancies and, aside from anti-hypertensives to try to control spiraling blood pressure, the only “cure” is delivery.

As a father of six, Donald Torry, PhD, has some experience with pregnancy. Helping women who develop preeclampsia has become his life’s work. Preeclampsia is a pregnancy condition in which high blood pressure and protein in the urine develop after the 20th week (late second or third trimester). Preeclampsia develops in 5-10 percent of pregnancies and, aside from anti-hypertensives to try to control spiraling blood pressure, the only “cure” is delivery.